Catalyst Wire Dossier Catalyst Wire Dossier

RPGR-XLRP gene therapy (AAV-RPGR)

RPGR gene therapy · Janssen Research & Development, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RPGR-XLRP gene therapy (AAV-RPGR), covering 2026-01-21 to 2026-01-21. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Follow-up Gene Therapy Study for RPGR- XLRP

See pricing